ESMO: European Cancer Disparities Drive Excess Cases

European Cancer Disparities Drive 29,412 Excess Cases Across Member States

A resident’s home country dramatically alters their risk of developing preventable cancers, resulting in 29,412 estimated excess cases across European Union member states with rates above the community average. The figures stem from an analysis presented at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid by epidemiologist Diego Serraino, a consultant for Alleanza Contro il Cancro, the national oncology network of the Italian Ministry of Health presided over by Ruggero De Maria. The research utilizes 2024 projections from the European Cancer Information System to compare incidence rates across 27 EU nations against continental averages, establishing a statistical measure of disparity rather than a count of definitively avoidable tumors.

Lung Cancer Rates Among Men Show Wide Margins Across Twelve Nations

European men face an estimated 199mila new lung cancer diagnoses, with a continental average of 89 cases per 100,000 individuals, according to data presented at the ESMO congress. National totals stretch from a low of 38 cases per 100,000 in Sweden to a high of 130 cases per 100,000 in Hungary—more than triple the Swedish rate. Twelve nations exceed the European average, accounting for 11,105 excess cases. Poland leads this group with 3,934 excess diagnoses, followed by Hungary with 1,734, Romania with 1,533, Greece with 1,391, and France with 1,348.

Danish Women Record Fourfold Higher Lung Cancer Incidence Than Lithuania

Among women, the continent records approximately 116mila new lung cancer diagnoses, reflecting an average incidence of 43 cases per 100,000 inhabitants. A stark geographical divide places Lithuania at the lower end with 20 cases per 100,000, while Denmark reaches 83 cases per 100,000—more than four times higher. Eleven EU states exceed the continental benchmark, generating 13,441 excess cases. Germany and the Netherlands record the highest volumes among female populations at 3,074 and 3,069 excess cases respectively, followed by Poland at 1,978, Hungary at 1,427, and Denmark at 1,325. Combined with male figures, lung cancer accounts for 24,546 excess diagnoses across the EU.

Cervical Cancer Disparities Peak With Romania Exceeding Malta Sevenfold

Cervical cancer exhibits the widest proportional gap between individual member states, with an estimated 28mila new diagnoses across the EU and an average incidence of 12 cases per 100,000 women. Romania registers 36 cases per 100,000 residents, compared to 5 cases per 100,000 in Malta, establishing a 7.2-to-1 ratio. Ten nations exceed the European average, contributing 4,866 excess cases. Romania accounts for 2,475 of those diagnoses, followed by Poland with 861, Bulgaria with 407, Hungary with 360, and Portugal with 263.

Preventive Public Health Policies Target Smoking and Human Papillomavirus

Effective anti-tobacco legislation remains the primary driver for reducing lung cancer incidence, while human papillomavirus (HPV) vaccination and organized screening programs govern cervical cancer outcomes. Screening participation allows clinicians to identify precancerous lesions before malignant transformation occurs. Serraino emphasized at the Madrid congress that these gaps indicate where healthcare systems must concentrate resources. The challenge lies in ensuring that preventive tools reach populations equitably, regardless of national borders or local administrative structures.

More on this story: Practice-Changing Cancer Trials: A Decade of ESMO Breakthroughs